title: Is there a role for antimicrobial stewardship in bronchiectasis?
authors.affiliation: Department of Infectious Diseases, Greenslopes Private Hospital, Brisbane, Queensland, Australia School of Medicine, University of Queensland, Brisbane, Queensland, Australia ian.gassiep@gmail.com.
authors.forename: I
authors.initials: I
authors.lastname: Gassiep
authors.affiliation: Department of Infectious Diseases, Greenslopes Private Hospital, Brisbane, Queensland, Australia School of Medicine, University of Queensland, Brisbane, Queensland, Australia.
authors.forename: A
authors.initials: A
authors.lastname: Chaudhuri
mesh_terms: D061605:Administration, Intravenous; D000284:Administration, Oral; D000900:Anti-Bacterial Agents / Q000008:administration & dosage / Q000627:therapeutic use*; D001987:Bronchiectasis / Q000150:complications*; D002939:Ciprofloxacin / Q000008:administration & dosage / Q000627:therapeutic use*; D024881:Drug Resistance, Bacterial; D019983:Guideline Adherence; D006801:Humans; D057970:Inappropriate Prescribing; D008485:Medical Audit; D017410:Practice Guidelines as Topic; D011552:Pseudomonas Infections / Q000150:complications / Q000188:drug therapy*
chemical_list: D000900:Anti-Bacterial Agents; D002939:Ciprofloxacin
keywords: Antimicrobial stewardship; bronchiectasis; ciprofloxacin; infective exacerbation; management